Bracket to Demonstrate Technology that Brings Pharmaceutical Companies Closer to their Patients at DIA Annual Meeting 2018

Visit booth #2522 to improve the patient experience, enable more reliable data capture in clinical trials, and watch (and play) plenty of soccer

King of Prussia, PA – Bracket, a technology company connecting patients to potentially life-changing therapies through faster and more reliable clinical research, will engage with clinical research leaders to showcase solutions that bring pharmaceutical companies closer to their patients at the DIA Annual Meeting in Boston, MA, from June 24-28, 2018.

Exhibit booth #2522 will be an active center for technology demonstrations and insightful conversations with sponsors and CROs determined to improve the patient experience and capture better, more reliable data worldwide.

Schedule a demo to experience the value of Bracket solutions firsthand.

  • Bracket eCOA: A mobile data collection solution that engages patients, caregivers, and clinical site staff. It can be used on provisioned or personal devices and includes robust services for scale management, data management, logistics, and outcomes advisory.
  • Bracket Patient Engagement: A mobile app and reminder system proven to boost patient compliance and study completion. It has been used by 18 of the top 20 pharmaceutical companies to engage research patients around the globe.
  • Bracket Neuroscience: An advanced solution for collecting clinician-rated endpoint data in neurology studies. Its advanced analytics and scientific services improve study data quality by maximizing rater reliability.
  • Bracket IRT & Clinical Supplies: An industry-trusted, quick-deploy solution for managing randomization and clinical supplies. It integrates seamlessly with Bracket SmartSupplies to forecast, label, distribute, manage and reconcile clinical supplies.

Visitors to the Bracket booth will also have the opportunity to share challenges and brainstorm best practices with subject matter experts including distinguished ePRO Consortium member Serge Bodart, Senior Adviser Outcomes Science, and Jeff Lee, President of eCOA and Patient Engagement, the patient technology innovator who founded mProve Health (acquired by Bracket in 2017).

In addition to technology discussions and live solution demonstrations, Bracket will help provide some well-deserved entertainment breaks with opportunities for casual fun:

  • Live viewings of global soccer tournament matches and a free-to-play foosball table
  • Daily raffles for an Amazon Echo Show
  • The “can’t miss” social event of the conference, Bracket’s annual party with CluePoints, this year to be held on Tuesday, June 26, at The Grand nightclub opening at 10pm. RSVP here then pick up your ticket at the Bracket booth.

“We are moving urgently to deliver new, high-impact capabilities for customers,” said Mike Nolte, Bracket CEO. “Inside Bracket, we’re adding even more expert talent to our team and investing in exciting new patient technology offerings built off years of established success. More importantly, we’re focused on connecting researchers and patients to accelerate the quality and speed of clinical trials through active engagement. Our industry has the noble responsibility to support longer and more productive lives for our families and communities around the world, and we are dedicated to supporting their success with great technology that patients love. I’m excited to share some of it with you at DIA.”

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

Bracket Appoints James Jay as Senior Vice President, Endpoint Solutions to Drive Continued Growth of Its Technology and Service Offerings

WAYNE, Pa., — June 5, 2018—Bracket, a leading clinical trial technology and specialty services provider, today announced James Jay has joined the Company as Senior Vice President, Endpoint Solutions, reporting to Bracket’s Chief Executive Officer, Mike Nolte. In this role, James will lead the Bracket business focused on eCOA, Rater Training, Analytics, Cognitive Testing, and Rater Quality technology solutions.

“James brings leadership, vision and creativity to Bracket’s growing team,” said Mike Nolte, CEO. “He will be essential in our ongoing efforts to build patient-centric, innovative technologies, advance our data and analytics strategy and support our pharmaceutical and biotechnology clients.”

James has 18 years of experience building successful software solutions for healthcare and life sciences. For the last six years he led the Global Imaging IT business at Agfa HealthCare, where he transformed the business strategy while creating a new market segment and established early market leadership. Prior to Agfa, James spent 13 years at GE, where he led the Global Cardiology IT business, and held other roles across R&D and program management.

James has an MBA in Global Management from American Intercontinental University and a BS in Computer Science from the University of Oregon.

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Media Contacts

Kristen Everett, Sagefrog, kristene@sagefrog.com

Kris Sarajian, Kristopher.Sarajian@bracketglobal.com

Bracket Appoints Mitch Blumenfeld as Chief Financial Officer

WAYNE, Pa., — May 22, 2018 – Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Mitch Blumenfeld as Chief Financial Officer.

Blumenfeld has extensive experience as a financial leader for life science and technology companies. He joins Bracket from PCI Pharma Services, the world’s largest provider of outsourced pharmaceutical packaging and related services where he was responsible for all financial management for 18 facilities across North America, Europe and Australia, led a successful exit to Partners Group and completed five acquisitions in four years.

“The opportunity to help a great business into their next phase of growth is a tremendous opportunity,” said Blumenfeld. “I’m looking forward to the chance to continue my personal investment in the clinical research industry and to support Bracket’s mission to improve the patient experience, while delivering speed and reliability in clinical trials.”

Prior to his time with PCI, Blumenfeld served in business leadership roles at a variety of clinical and technology businesses. From 2006 to 2013 Mitch worked for AmerisourceBergen as the Senior Vice President and CFO of the Drug Corporation and led the integration and finance functions for World Courier, the world leader in global cold chain and clinical trial logistics with offices in over 140 countries.

“Mitch is an outstanding and proven CFO, with a tremendous track record and deep experience transforming and growing great businesses,” said Mike Nolte, CEO at Bracket.  “I’m proud to have him on this team and I look forward to working together to lead Bracket’s future growth.”

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Media Contacts

Kristen Everett, Sagefrog Marketing Group, kristene@sagefrog.com

Adam Butler, Bracket, adam.butler@bracketglobal.com

Bracket Appoints Serge Bodart to Scientific Leadership as eCOA Subject-Matter Expert

May 01, 2018, Wayne, PABracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Serge Bodart, MS, as Senior Advisor, Outcomes Science, where he will build upon the existing breadth and depth of Bracket’s scientific and technical thought leadership while serving specifically as the Company’s electronic clinical outcomes assessments (eCOA) subject-matter expert.

Serge is a seasoned clinical trial technology executive who has been immersed in the eCOA and patient reported outcomes (ePRO) industry for more than 20 years. In addition to serving as a member of the ePRO Consortium for the past four years, Serge also Co-founded and served as Chief Executive Officer to Symfo, a European-based ePRO provider. With international entrepreneurial experience in the space, Serge brings an impressive level of functional and technical knowledge about eCOA to Bracket, understanding its lifecycle from concept to commercialization and its impacts on sites and patients.

“Joining Bracket’s scientific team in a leadership capacity is an exciting opportunity,” said Serge. “I look forward to not only improving how researchers engage with patients in clinical trials on a larger, global scale through Bracket’s advanced and comprehensive eCOA platform, but also helping to legitimize the use of technology in clinical trials as a whole by generating greater awareness with thought leadership.”

In his role as Senior Advisor, Outcomes Science, Serge will provide scientific oversight for all of Bracket’s ePRO activities, and will contribute to our research and new product development initiatives.

“We are pleased to welcome Serge to Bracket and further advance our flagship eCOA and ePRO product suite with his diverse perspectives, unparalleled enthusiasm and subject-matter expertise,” said Jeff Lee, President, mProve Health, a Bracket Company. “His impressive track record of transformational leadership will be a major asset to our rich pipeline of impending and long-term innovations to our eCOA and ePRO platforms, and to advancing the use and adoption of technology in clinical trials a whole.”

Prior to his eCOA career, Serge served as Major and helicopter pilot for more than 20 years in the Belgian Army Aviation. He is currently based in Montreal, Canada and holds a M.S. degree in Telecommunications from the Polytechnic Division of the Royal Military Academy in Brussels, Belgium.

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.

Contact

Kristen Everett
Sagefrog Marketing Group on behalf of Bracket
kristene@sagefrog.com | 267-357-7018

Bracket’s ePRO Solution Wins CARE Award for Best Patient-Focused Technological Development

Bracket, a leading clinical trial technology and specialty services provider, has won the Best Patient-Focused Technological Development award at the Clinical and Research Excellence (CARE) Awards. The award, which acknowledges 2018’s best advancement in improving data collection and the patient experience, recognizes the success of Bracket’s ePRO and patient engagement solution in boosting study compliance and completion by making patients feel like partners in their clinical trial.

Commenting on the award, Bracket’s President, eCOA and Patient Engagement, Jeff Lee, said: “We are delighted that our solution has been recognized by the CARE Awards’ 2018 judging panel. Patients are the lifeblood of clinical trials and we set out with the goal of building a comprehensive ePRO solution that would make them feel like ‘partners’ in their clinical trial rather than merely a ‘data set’. Bracket’s mobile ePRO solution goes beyond delivering robust trial instruments—it leads with BYOD capabilities and includes patient engagement features alongside integrations to complementary third-party solutions, such as eConsent, payments and lab courier services to improve the patient experience.”

Bracket’s ePRO solution works on iPhone and Android operating systems for seamless use on provisioned or personal devices. In a single mobile touchpoint patients access validated survey instruments as well as everything they need to feel empowered and informed for the duration of the clinical trial, including: personalized reminders (via text-message or push notification), visit schedule information, the ability to confirm or cancel appointments, multimedia reference tools, gamification, direct-from-site communications, and third party study services. The mobile app makes it easy for patients to keep up with their study commitments and eliminates the need to use multiple, disparate technologies. In a recent clinical study, patients who used Bracket’s ePRO and engagement solution were more likely to comply with the study protocol, complete their diaries, and were up to 80% less likely to withdraw from the study.

The CARE Awards acknowledge and applaud the pharmaceutical sector’s outstanding performers across all areas of the industry, recognizing both corporate and individual achievements. To see the full list of 2018 CARE Awards winners please visit: https://pharmaintelligence.informa.com/events/awards/care-awards-2018

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products – Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.

About Informa PLC

Informa operates at the heart of the Knowledge and Information Economy. It is one of the world’s leading business intelligence, academic publishing, knowledge and events businesses. With more than 6,500 employees globally, it has a presence in all major geographies, including North America, South America, Asia, Europe, the Middle East and Africa.

Bracket Appoints Michael Nolte as New CEO

WAYNE, Pa., — Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Michael P. Nolte as Chief Executive Officer. The company’s current CEO, Jeff Kinell, will remain on the Bracket Board of Directors as a strategic advisor.

Mike Nolte is a seasoned industry leader who joins Bracket after serving as the Chief Executive Officer of Influence Health, where he led the strategy and delivery for the Consumer Experience Platform, supporting consumer-centric, digital healthcare. With a career spent at the intersection of healthcare, technology and service delivery, Nolte’s breadth of experience, strategic insight and proven track record align well with Bracket’s goals as it continues to invest in science-based,  clinical development technology and service solutions.

“I am thrilled to join the Bracket team, and I look forward to this unique opportunity in an outstanding business at a unique and pivotal moment,” said Nolte, CEO of Bracket. “This is an exceptional chance to relentlessly pursue value for our customers, broaden our impact on clinical trials, and transform how clinical research is conducted by using technology and data to improve patient outcomes.”

Prior to Influence Health, Mike served as the President and COO of MedAssets and spent 7 years at GE, where he led GE’s Healthcare IT Service Business in the Americas, served as the GM of GE’s Enterprise Revenue Cycle Business and led business transformation activities for GE’s Chief Information Officer. Mike’s early career included five years with McKinsey & Company and six years as a U.S. Army Officer. He holds a Master of Business Administration degree from The University of Chicago Booth School of Business and a Bachelor’s Degree from the University of Notre Dame.

“Mike is the ideal leader for Bracket as we scale the business and broaden the company’s impact on clinical research,” said David Golde, Director at Genstar Capital. “With Mike’s deep background in healthcare, his successful track record as a technology executive and his pragmatic leadership style, I’m confident in his ability to accelerate Bracket’s growth initiatives, both organically and through acquisitions, as Bracket continues to increase the value proposition it provides to its customers. We are also very grateful for Jeff Kinell’s integral role in establishing Bracket as a market leader, and we are pleased that he will continue to be involved with Bracket as a strategic advisor to the company.”

About Bracket
Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Bracket Strengthens Global Growth and Development Strategy with New Chief Commercial Officer, Christopher Crucitti

WAYNE, Pa., — Bracket, a leading clinical trial technology and specialty services provider, today announced the addition of Christopher Crucitti, Chief Commercial Officer to its global executive team. Crucitti joins Bracket as an experienced commercial leader in clinical and R&D services.

Crucitti brings industry-recognized experience, knowledge and integrity to Bracket’s leadership team as well as notable accomplishments in training and motivating other commercial professionals to provide a high level of customer service and overall performance. He will be responsible for the global commercial strategy and development of Bracket’s electronic clinical outcomes assessments (eCOA) and patient engagement platform, Randomization and Trial Supply Management (RTSM), Rater Training and Quality Assurance as well the Company’s expanding mobile suite for patient diary and analytics, among others.

“It’s with great excitement that we welcome Chris to our leadership team,” said Jeff Kinell, CEO at Bracket. “Chris brings an impressive resume in clinical commercial strategy to Bracket and has joined us at a pivotal time, as we continue to position ourselves competitively in the global marketplace through the increased use of Bring Your Own Device mobile solutions for patient engagement. We look forward to the unique and seasoned perspective Chris will bring to our team and global commercial strategy.”

Prior to joining Bracket, Crucitti served as Chief Commercial Officer at Science Exchange, a world-leading marketplace for outsourced research and as Executive Vice President, Global Business Development at Worldwide Clinical Trials, Inc., a global CRO that provides full-service drug development services to the pharma and biotech industries. Crucitti also held senior roles at InVentiv Health Clinical and i3 Research, a pharmaceutical services company that provides integrated solutions throughout the product lifecycle.

“I’m extremely excited to join Bracket, with its many smart and committed team members, leveraging my experience in clinical development services and technology to further optimize our commercial growth strategy,” said Crucitti, Chief Commercial Officer at Bracket. “With recent and imminent expansion on the horizon, the ability to communicate how our suite of technologies and solutions empower patient engagement to ultimately improve outcomes will be paramount; I look forward to the challenge and the many opportunities to expedite the process of getting meaningful treatments in the hands of patients that need them.”

Crucitti earned his Masters of Science in Health Management from American University and his Bachelors of Science in Cardiac Rehabilitation and Exercise Science from Ithaca College.

About Bracket
Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Bracket Acquires mProve Health to Radically Advance Patient Engagement in Clinical Trials

Wayne, Pa, — Bracket, a leading clinical trial technology and specialty services provider, today announced the strategic acquisition of mProve Health Inc. (mProve), a leading provider of mobile technologies for life science companies. The acquisition centers on both companies’ support of tech-enabled clinical trials that improve patient engagement through the use of “Bring Your Own Device” mobile tools in clinical trials.

Early-to-market with Electronic Clinical Outcomes Assessments (eCOA) and the first Randomization and Trial Supply Management (RTSM) mobile application, Bracket is at the forefront of digitization in clinical trials. Bracket helps biopharmaceutical sponsors and CROs increase the power of their data and identified a need to bring greater accuracy through technology. Included in mProve’s suite of regulatory compliant mHealth solutions is mPulse, an Electronic Patient-Reported Outcomes (ePRO) platform for enabling data collection via standalone native mobile apps or SMS text.  Other apps will enable communication with doctors and provide reminders and education.

In a recent report by KNect365, 94% of clinical trials professionals surveyed are looking to increase the utilization of mHealth, surpassing big data (86%) and cloud technology for EMRs (84%). These findings, among others, indicate mHealth technology as one of the most powerful opportunities in clinical trials. While mainstream eCOA providers are challenged to retrofit their systems to support emerging mHealth technologies and the BYOD movement, Bracket is now positioned for success with native mHealth capability.

“We are excited to announce the acquisition of mProve as we take a major step forward in our support of tech-enabled clinical trials,” said Jeff Kinell, CEO of Bracket. “As an early adopter of mHealth and BYOD, we recognize how these movements empower patients to become partners in their trials, and subsequently, deliver more accurate PRO and increase the likelihood of a successful trial.”

“This acquisition is an opportunity to bring the shared visions of mProve and Bracket into focus,” said Jeff Lee, CEO of mProve. “Both organizations center on improving patient engagement and driving adoption of the mHealth to do so. Together, we are well situated for a future of tech-enabled clinical trials.”

David Golde, Director at Genstar Capital, commented, “We are excited to be supporting Bracket’s first acquisition under Genstar ownership. Combined, Bracket and mProve’s solutions will deliver increased value to clinical trials through the greater use of technology. We look forward to working with Bracket management to continue pursuing strategic acquisitions that allow Bracket to better serve its customers.”

About mProve Health
mProve Health is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments (eCOA). mProve’s applications are used by 18 of the top 20 pharmaceutical companies, 15,000 clinical research sites in over 60 countries, and they are translated in over 50 languages to support patients across the globe. The company was founded in 2010 by Jeff Lee, CEO, an entrepreneur and mobile engagement strategist who founded three prior successful ventures, and Denis Curtin, PhD, CSO, a pharmacologist and pharmaceutical industry veteran. Learn more at www.mprove.com.

About Bracket
Bracket, with nine offices and more than 700 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.

About Genstar Capital
Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $9 billion and targets investments focused on targeted segments of the industrial technology, healthcare, financial services, and software industries.

Bracket Welcomes New Chief Technology Officer Sam Whitaker

Wayne, PA – Bracket, a leading clinical trial technology and specialty services provider, today welcomed Sam Whitaker as Chief Technology Officer (CTO) to its growing team. Whitaker joins Bracket’s leadership team bringing ten years of experience in clinical technology and global infrastructure innovation to the Company.

Whitaker will be responsible for Bracket’s global product strategy, management and innovation, technology development and engineering including architecture, user experience (UX), user interface (UI) and IT support functions. Whitaker will leverage his ten years’ experience as co-founder and CEO of Greenphire, the first clinical technology to bring payment technology to the clinical environment.

During his tenure at Greenphire, Whitaker invented and successfully commercialized the first clinical trial payment technologies. The web-based applications were built on top of a global technology infrastructure, which he and his team designed to support the unique needs of sponsors, clinical research organizations (CROs) and sites and scaled to support more than 500 clients globally.

“Sam Whitaker joins Bracket with highly specific knowledge of clinical trial technology and a complete understanding of our technological vision,” said Jeff Kinell, CEO of Bracket. “As we continue to solidify our position as a global leader in clinical trial technology and specialty services, it’s imperative that we partner with our industry’s most innovative minds to lead and implement industry-wide advancements.”

Prior to Greenphire, Whitaker worked in the product division of Citigroup, designing technology solutions across verticals. He graduated from the University of Pennsylvania.

About Bracket

Bracket, with nine offices and more than 700 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Bracket Expands Team with Industry Leader Dr. Amir Kalali

Wayne, PA – Bracket, a leading clinical trial technology and specialty services provider, today introduced Amir Kalali, MD, as its Executive Advisor for Global Strategy . Dr. Kalali joins Bracket as a recognized leader in drug development methodology and technological innovation.

Dr. Kalali will work with Bracket’s leadership to help identify innovative technologies to support the evolution of its integrated growth. In addition, Dr. Kalali will assist in the acceleration of growth in Bracket’s CNS product lines in other fields of medicine.  He is Professor of Psychiatry at University of California San Diego, Editor of the journal Innovations in Clinical Neuroscience, and the Lead Editor of the book Essential CNS Drug Development, published by Cambridge University Press. He has authored over 150 peer-reviewed publications.

Previously, Dr. Kalali was Global  Head of the Neuroscience Center of Excellence at Quintiles IMS, where he was responsible for the enterprise-wide strategy for neuroscience, encompassing drug development and healthcare services.

Recognized globally as a leader in drug development and healthcare with an emphasis on  innovation, collaboration, and the intersection with new technology, Dr. Kalali was the Founding Chairman of the Executive Committee of the International Society for CNS Drug Development  (ISCDD), a founding member of the International Society for CNS Clinical Trials and  Methodology (ISCTM), where he serves on Executive Committee, the Scientific Committee, and  previously chaired the Membership and Publication Committees. He is also a founder and Co- Chair of the Scientific Program Committee of the CNS Summit, and serves on the Scientific Program Committee of the American College of Neuropsychopharmacology. Dr. Kalali regularly presents at national and international scientific meetings, and lectures  frequently on drug development, innovation, technology, digital medicine and health.  He is an advisor to the Center for Digital Transformation at the Paul Merage School of Business  at the University of California, Irvine.

“We are  thrilled  to welcome Dr. Kalali to Bracket,” said David G. Daniel, MD, Senior Vice President and Chief Medical Officer of Bracket. “Dr. Kalali’s depth and breadth of knowledge of clinical trial methodology and emerging technologies is unparalleled. We anticipate that Dr. Kalali will become a major contributor to Bracket’s  growth in eCOA, rater training and data quality monitoring solutions.” During his career, Dr. Kalali has been recognized five times by PharmaVOICE magazine as one of the 100 most inspiring leaders in life sciences. In 2014, he was awarded the PharmaVOICE Red Jacket Award in recognition of his career-long contributions to the industry.

Dr. Kalali earned his medical degree from the University of London and completed his psychiatry training at University College and Middlesex School of Medicine, University of London.

About Bracket
Bracket, with nine offices and more than 700 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.